Table 3.
Cox regression model in non-white subjects who undergone lung transplant for COPD, IPF and sarcoidosis in the US in from December 2005 through December 2015.
| Variable | Hazard Ratio | Lower 95% | Upper 95% | p value |
|---|---|---|---|---|
| Double lung | 1.0228 | 0.8440 | 1.239 | 0.81821 |
| COPD | 1.0415 | 0.7938 | 1.366 | 0.76935 |
| IPF | 1.1241 | 0.8944 | 1.413 | 0.31574 |
| Age (recipient) | 1.0125 | 1.0028 | 1.022 | 0.01100 |
| Male (recipient) | 1.0497 | 0.8760 | 1.258 | 0.59933 |
| Mechanical ventilation | 1.1637 | 0.7514 | 1.802 | 0.49694 |
| Ischemic time | 1.0457 | 0.9917 | 1.103 | 0.09855 |
| Caucasian (donor) | 0.9556 | 0.8100 | 1.127 | 0.58989 |
| Male(donor) | 1.0585 | 0.8820 | 1.270 | 0.54148 |
| Age (donor) | 1.0095 | 1.0035 | 1.015 | 0.00188 |
| LAS Era | 1.0006 | 0.9950 | 1.006 | 0.83991 |